MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1490.52%
Quick Ratio
1490.52%
Cash Ratio
299.90%
Debt to Asset Ratio
7.75%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Other long-term assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Lease liabilities, noncurrent
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
73,835
84,955
77,387
61,951
Marketable securities
280,109
298,511
178,616
212,973
Prepaid expenses and other current assets
13,022
11,147
9,447
6,292
Total current assets
366,966
394,613
265,450
281,216
Restricted cash
884
884
1,000
1,000
Property and equipment, net
1,173
1,215
1,314
1,346
Right-of-use asset
5,311
5,443
5,573
5,699
Other long-term assets
9,028
9,885
9,272
12,590
Total assets
383,362
412,040
282,609
301,851
Accounts payable
2,334
3,642
1,178
1,991
Lease liabilities, current
504
488
472
456
Accrued expenses and other current liabilities
21,782
15,126
16,444
13,432
Total current liabilities
24,620
19,256
18,094
15,879
Lease liabilities, noncurrent
5,078
5,209
5,338
5,463
Other long-term liabilities
-
-
0
0
Total liabilities
29,698
24,465
23,432
21,342
Common stock, 0.0001 par value 500,000,000 shares authorized at june 30, 2026 and december 31, 2025 59,662,877 and 53,706,357 shares issued and outstanding june 30, 2026 and december 31, 2025, respectively
6
6
5
5
Additional paid-in capital
810,359
798,025
630,037
617,486
Accumulated other comprehensive income (loss)
-580
107
393
442
Accumulated deficit
-456,121
-410,563
-371,258
-337,424
Total stockholders' equity
353,664
387,575
259,177
280,509
Total liabilities and stockholders' equity
383,362
412,040
282,609
301,851
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$280,109K (41.63%↑ Y/Y)Cash and cashequivalents$73,835K (-25.03%↓ Y/Y)Prepaid expenses andother current assets$13,022K (121.31%↑ Y/Y)Total current assets$366,966K (21.45%↑ Y/Y)Other long-termassets$9,028K (-18.73%↓ Y/Y)Right-of-use asset$5,311K Property and equipment,net$1,173K (-16.99%↓ Y/Y)Restricted cash$884K (-11.60%↓ Y/Y)Total assets$383,362K (19.24%↑ Y/Y)Total liabilities andstockholders' equity$383,362K (19.24%↑ Y/Y)Total stockholders'equity$353,664K (17.05%↑ Y/Y)Total liabilities$29,698K (53.46%↑ Y/Y)Accumulated deficit-$456,121K (-48.31%↓ Y/Y)Accumulated othercomprehensive income (loss)-$580K (-233.03%↓ Y/Y)Additional paid-in capital$810,359K (33.01%↑ Y/Y)Total currentliabilities$24,620K (78.79%↑ Y/Y)Lease liabilities,noncurrent$5,078K (-9.03%↓ Y/Y)Common stock, 0.0001par value...$6K (20.00%↑ Y/Y)Accrued expenses andother current...$21,782K (96.52%↑ Y/Y)Accounts payable$2,334K (3.96%↑ Y/Y)Lease liabilities,current$504K (14.29%↑ Y/Y)

Tyra Biosciences, Inc. (TYRA)

Tyra Biosciences, Inc. (TYRA)